Zhang, Z.; Gu, M.; He, G.; Yu, X.; Yang, J.; Wu, X.; Zhang, X.; Lu, K.; Qian, F.; Shi, X.;
et al. LHX2 Is a Potential Biomarker and Associated with Immune Infiltration in Breast Cancer. Cancers 2023, 15, 2773.
https://doi.org/10.3390/cancers15102773
AMA Style
Zhang Z, Gu M, He G, Yu X, Yang J, Wu X, Zhang X, Lu K, Qian F, Shi X,
et al. LHX2 Is a Potential Biomarker and Associated with Immune Infiltration in Breast Cancer. Cancers. 2023; 15(10):2773.
https://doi.org/10.3390/cancers15102773
Chicago/Turabian Style
Zhang, Ziwei, Minghao Gu, Gao He, Xiafei Yu, Junzhe Yang, Xian Wu, Xiaoqiang Zhang, Kaining Lu, Fangze Qian, Xiaoyue Shi,
and et al. 2023. "LHX2 Is a Potential Biomarker and Associated with Immune Infiltration in Breast Cancer" Cancers 15, no. 10: 2773.
https://doi.org/10.3390/cancers15102773
APA Style
Zhang, Z., Gu, M., He, G., Yu, X., Yang, J., Wu, X., Zhang, X., Lu, K., Qian, F., Shi, X., Xu, J., Zhuang, M., Liu, X., & Zhu, Y.
(2023). LHX2 Is a Potential Biomarker and Associated with Immune Infiltration in Breast Cancer. Cancers, 15(10), 2773.
https://doi.org/10.3390/cancers15102773